CYCLO THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 20th, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Florida
Contract Type FiledOctober 20th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is made and entered into as of October 20, 2023, by and among Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), and the investors identified on the signature pages hereto (each a “Purchaser”, and collectively, the “Purchasers”).
CYCLO THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 5th, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Florida
Contract Type FiledJune 5th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is made and entered into as of June 1, 2023, by and among Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), and Rafael Holdings, Inc., a Delaware corporation (“Purchaser”).